Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Paul Phillips

    TitleClinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0835
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Taub PR, Ramirez-Sanchez I, Patel M, Higginbotham E, Moreno-Ulloa A, Román-Pintos LM, Phillips P, Perkins G, Ceballos G, Villarreal F. Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial. Food Funct. 2016 Sep 14; 7(9):3686-93. PMID: 27491778; NIHMSID: NIHMS808667 [Available on 09/14/17].
        View in: PubMed
      2. Fernandez G, Spatz ES, Jablecki C, Phillips P. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med. 2011 Jun; 78(6):393-403. PMID: 21632911.
        View in: PubMed
      3. Linares LA, Golomb BA, Jaojoco JA, Sikand H, Phillips P. The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening. Curr Drug Saf. 2009 Sep; 4(3):181-7. PMID: 19534642.
        View in: PubMed
      4. Phillips P. Balancing randomized trials with anecdote. Ann Intern Med. 2009 Jun 16; 150(12):885-6. PMID: 19528568.
        View in: PubMed
      5. Phillips P, Ciaraldi TP, Kim DL, Verity MA, Wolfson T, Henry RR. Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids. Endocrine. 2009 Feb; 35(1):38-46. PMID: 19051066.
        View in: PubMed
      6. Phillips P, Haas RH. Statin myopathy as a metabolic muscle disease. Expert Rev Cardiovasc Ther. 2008 Aug; 6(7):971-8. PMID: 18666847.
        View in: PubMed
      7. Vladutiu GD, Simmons Z, Isackson PJ, Tarnopolsky M, Peltier WL, Barboi AC, Sripathi N, Wortmann RL, Phillips P. Genetic risk factors associated with lipid-lowering drug-induced myopathies. Muscle Nerve. 2006 Aug; 34(2):153-62. PMID: 16671104.
        View in: PubMed
      8. Phillips P, Haas RH. Observations from a statin myopathy clinic. Arch Intern Med. 2006 Jun 12; 166(11):1232-3; author reply 1233. PMID: 16772252.
        View in: PubMed
      9. Antons KA, Williams CD, Baker SK, Phillips P. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med. 2006 May; 119(5):400-9. PMID: 16651050.
        View in: PubMed
      10. Havranek JM, Wolfsen AR, Warnke GA, Phillips P. Monotherapy with ezetimibe causing myopathy. Am J Med. 2006 Mar; 119(3):285-6. PMID: 16490482.
        View in: PubMed
      11. Sikand H, Jaojoco J, Linares L, Phillips P. Atypical antipsychotic drugs, dementia, and risk of death. JAMA. 2006 Feb 1; 295(5):495; author reply 496-7. PMID: 16449610.
        View in: PubMed
      12. Phillips P. How common is rhabdomyolysis in patients receiving lipid-lowering therapy? Nat Clin Pract Cardiovasc Med. 2005 Mar; 2(3):130-1. PMID: 16265453.
        View in: PubMed
      13. Phillips P. Ezetimibe and statin-associated myopathy. Ann Intern Med. 2004 Oct 19; 141(8):649. PMID: 15492351.
        View in: PubMed
      14. Phillips P, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, Vladutiu GD, England JD. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002 Oct 1; 137(7):581-5. PMID: 12353945.
        View in: PubMed